Wellmedr vs TMates: Price, Doctor Access, and Compounding Differences
Quick verdict: Wellmedr competes on low starting price and lifetime locked-in pricing while TMates emphasizes flat $199/month pricing with 24/7 U.S. doctor access. This comparison highlights price, clinician access and coverage, compounded medication notes, shipping and plan guarantees, and available medications so you can decide between Wellmedr vs TMates.
See Wellmedr plans starting at $89/mo
Head-to-head summary table: Wellmedr vs TMates
| Criteria | Wellmedr | TMates |
|---|---|---|
| Starting price | Semaglutide from $89/mo, 1-Year Plan | $199/month flat, same price at every dose |
| Doctor access and coverage | All treatment plans require medical evaluation and clinician approval; availability based on state eligibility | 24/7 access to U.S.-based doctors, licensed coverage in all 50 states |
| Compounded medication status | Offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies; not evaluated by the FDA for safety or efficacy | Clinically dosed compounded semaglutide formulated in U.S. facilities; compounded, not FDA-approved finished product |
| Medication options | Lists semaglutide and tirzepatide plans; mentions Ozempic and Zepbound pricing examples | Compounded semaglutide primarily; limited public detail on tirzepatide availability |
| Shipping and guarantees | Same-day review + free overnight shipping; money back guarantee claim captured on landing page | Free shipping; virtual check-ins and cancel anytime policy |
Price and plan structure compared
Price is the clearest difference in Wellmedr vs TMates. Wellmedr advertises GLP-1 plans starting at $89/month and specific monthly semaglutide plans starting at $49 a month in some listings, with multiple promotional offers captured on the landing page. Wellmedr also markets lifetime locked-in pricing and a New Customer Offer claiming $150 off for life. TMates positions a flat $199/month rate that stays the same at every dose and highlights predictable budgeting with no step-up fees as dose escalates.
Explore TMates flat $199/month program
Clinician access, state coverage, and oversight
Both providers require clinician review but their emphasis differs. TMates explicitly advertises 24/7 access to U.S.-based doctors and licensed coverage in all 50 states. Wellmedr requires medical evaluation and clinician approval and notes availability can depend on state eligibility. If continuous physician availability across all states matters, the evidence supports TMates on that point.
Compounded medication status and safety notices
Wellmedr and TMates both offer compounded GLP-1 medications and each source captures regulatory qualifiers. Wellmedr states its compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy and includes an explicit Required Safety Notice about risks such as thyroid C-cell tumors and medullary thyroid carcinoma. TMates notes its semaglutide is compounded and not an FDA-approved finished product while emphasizing U.S.-based formulation facilities. These are factual, captured statements rather than clinical endorsements.
Confirm Wellmedr eligibility and compounding info
Shipping, guarantees, and program features
Wellmedr lists same-day review and free overnight shipping along with claims of on-time refills and a money back guarantee captured on the landing page. TMates highlights free shipping, virtual check-ins, cancel anytime, and clinician-supervised dosing. Both stress that availability is subject to medical eligibility and clinician review.
Medication options and titration
Wellmedr lists plans for semaglutide and tirzepatide and references branded examples in pricing statements. TMates focuses on compounded semaglutide with limited public detail on tirzepatide availability. Neither source provides comparative clinical outcome data in the captured evidence.
Check Wellmedr medication plan details
How to choose between Wellmedr vs TMates
Choose Wellmedr if you prioritize lower advertised starting prices, lifetime locked-in pricing promises, and captured claims of same-day review with free overnight shipping. Choose TMates if you prioritize flat $199/month pricing that does not increase with dose, explicit 24/7 U.S. doctor access, and licensed coverage in all 50 states. Both offer compounded medications and require clinician review and medical eligibility. The sources do not supply comparative clinical outcome data or insurance billing details beyond the statements above.